* CareMax Inc CMAX.OQ CMAX.O is expected to report
results on
March 8.
* The Miami Florida-based company is expected to report
revenue
of $118.446 million, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for CareMax Inc is for
a loss
of 6 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for CareMax Inc
is
$14, about 57.2% above its last closing price of $5.99.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.08 -0.08 -0.03 Beat 63.6
Jun. 30 2021 -0.04 -0.04 -0.26 Missed -550
This summary was machine generated March 4 at 18:05 GMT. All
figures in US dollars unless otherwise stated